The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1057
July 16, 1999
View Complete Issue         Table of Contents 2019 
Issue 1057
Subscribers: Log in to read full issue.  Not a subscriber?  Subscribe or purchase issue.
Cosmetic Use of Botulinum Toxin
July 16, 1999 (Issue: 1057)
Botulinum toxin type A has been marketed in the USA since 1989 for treatment of strabismus and blepharospasm and has also been used to treat cervical dystonia and some other muscular disorders.
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this issue?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App for iOS, Android, and Kindle Fire
  • FREE online per issue CME/CE
Purchase this issue:
Title: Issue 1057
 


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.